cardiac-surgery-heart-congress-2019-scientifictracks

Page 14

allied

academies

Current Trends in Cardiology | Volume: 03

WORLD HEART CONGRESS

International Congress on

CARDIOLOGY AND CARDIAC SURGERY

December 02-03, Dubai, UAE

Joint event on

Curr Trend Cardiol, Volume: 03

Notes:

Sens a heart vs hs-cTnI for rapid diagnosis of ACS

Nikola Bakracheski, Elena Kovacheska Bashuroska

Institute of Cardiovascular Diseases, Macedonia

ens a heart is a unique, novel ultra-sensitive

immunoassay for the rapid diagnosis of myocardial

infarction (myocardial injury) in early phase of ischemic

coronary cascade and in the lates stage of development

of myocardial necrosis. The test is qualitative lateral flow

immunochromatographic assay for the rapid detection

of Cardiac Troponin I ( cTnI) and Heart Fatty Acid Binding

Protein ( H-FABP), which in combination can detect early

signs of AMI (ACS) as soon as 30 minutes after symptom

onset, as compared to the 4 hours wait time of hs-cTnI.

The most significant advantage of Sense-a Heart,

compared to hs-cTnI is its simplicity and easy to use 10

minute test, taken in the early period of ACS, require no

measurement instruments and it can be easly deployed

at the bedside, at the point of patient care, in physician

office, emergency service areas, ambulances without any

laboratory equipment. It requires only a single droplet of

blood (30μL), and it has prominent diagnostic sensitivity

and specificity in patients with ACS.

Biography

Nikola Bakracheski is the head of Interventional Cardiology Department

and Coordinator of Scientific club and CME at the Institute of

Cardiovascular Diseases – Ohrid, Macedonia. He has completed his

PhD studies in 2016 at University Ss Cyril and Methodius-Skopje. He

is a coauthor of several books and scientific papers in the field. He is

a member of ESC, EAPCI, Macedonian Society of Cardiology and the

Macedonian Medical Association.